CD4 and Parkinson disease: Studies in our lab identified a subtype of CD4+ T cells in MPTP(1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mice, which was abolished by calpaininhibitor administration, suggesting activation of calpain plays a role in CD4+ T cellactivation in PD.